Medicare Enrolled
Dr. Joanna Geslani, D.O.
Internal Medicine · Dallas, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Geslani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Geslani?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Geslani
Dr. Joanna Geslani is an internal medicine specialist in Dallas, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Geslani performed 5,340 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Geslani received a total of $192,365 from 52 pharmaceutical and/or device companies across 2025 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Geslani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ Top 6% volume in TX
$192,365 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,340
Medicare services
Top 6% in TX for internal medicine
Not available
Unique patients (not deduplicated)
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,280 | $18 | $69 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
316 | $10 | $32 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
314 | $90 | $376 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
295 | $8 | $23 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
293 | $8 | $27 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
276 | $5 | $16 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
275 | $3 | $8 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
238 | $58 | $217 |
| Complement and antigen measurement A laboratory test to measure levels of complement proteins and antigens in the blood. |
156 | $12 | $36 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
70 | $28 | $89 |
| Rheumatoid factor level | 64 | $5 | $17 |
| Screening test for antibody to noninfectious agent A laboratory test that screens for the presence of antibodies produced in response to a noninfectious agent. |
57 | $12 | $36 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
57 | $129 | $530 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
51 | $4 | $14 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
50 | $18 | $54 |
| New patient office visit, complex (60-74 min) | 47 | $164 | $648 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
45 | $3 | $10 |
| Hepatitis B core antibody test A blood test that measures the level of antibodies to the hepatitis B core antigen. This test helps determine if a person has been infected with the hepatitis B virus. |
45 | $12 | $36 |
| Hepatitis B surface antibody test A blood test that measures the level of antibodies against the hepatitis B surface antigen. This test is used to check for immunity to hepatitis B or to verify the effectiveness of the hepatitis B vaccine. |
45 | $10 | $32 |
| Hepatitis C antibody test A blood test that checks for antibodies to the hepatitis C virus. This test helps determine if a person has been exposed to the virus. |
45 | $14 | $43 |
| Hepatitis B surface antigen test A blood test that uses an immunoassay technique to detect the presence of the hepatitis B surface antigen. This test identifies whether the hepatitis B virus is currently present in the body. |
45 | $10 | $31 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
42 | $16 | $50 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
42 | $12 | $39 |
| Autoimmune disorder screening test A laboratory test used to screen for the presence of autoimmune disorders. |
34 | $12 | $36 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
31 | $64 | $267 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
30 | $2 | $7 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
23 | $31 | $80 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
21 | $72 | $587 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
14 | $6 | $20 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
13 | $13 | $41 |
| Iron level test | 13 | $6 | $19 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
13 | $9 | $26 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$192,365
Total received (2018-2024)
Avg $27,481/year across 7 years
Top 1% in TX for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
2,025
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$32,580
2023
$46,102
2022
$53,363
2021
$23,279
2020
$13,139
2019
$17,410
2018
$6,492
Payments by company (2024)
GlaxoSmithKline, LLC.
$19,146
AstraZeneca Pharmaceuticals LP
$8,363
ABBVIE INC.
$945
Amgen Inc.
$881
UCB, Inc.
$765
Janssen Biotech, Inc.
$469
Lilly USA, LLC
$303
Aurinia Pharma U.S., Inc.
$276
Novartis Pharmaceuticals Corporation
$257
PFIZER INC.
$226
E.R. Squibb & Sons, L.L.C.
$205
Organon Llc
$200
Mallinckrodt Hospital Products Inc.
$106
Janssen Scientific Affairs, LLC
$94
GENZYME CORPORATION
$88
Boehringer Ingelheim Pharmaceuticals, Inc.
$58
Kiniksa Pharmaceuticals International, plc
$56
Fresenius Kabi USA, LLC
$47
Kyowa Kirin, Inc.
$29
SOBI, INC
$22
SCILEX PHARMACEUTICALS INC.
$18
Zimmer Biomet Holdings, Inc.
$14
Genentech USA, Inc.
$13
Top 3 companies account for 87.3% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$99,318
AstraZeneca Pharmaceuticals LP
$46,755
Novartis Pharmaceuticals Corporation
$8,920
UCB, Inc.
$8,680
AbbVie, Inc.
$4,406
Amgen Inc.
$4,380
Janssen Biotech, Inc.
$3,010
ABBVIE INC.
$2,404
Lilly USA, LLC
$1,741
PFIZER INC.
$1,704
Horizon Therapeutics plc
$1,444
GENZYME CORPORATION
$1,420
AbbVie Inc.
$1,358
E.R. Squibb & Sons, L.L.C.
$1,274
Genentech USA, Inc.
$740
Aurinia Pharma U.S., Inc.
$672
Celgene Corporation
$553
Janssen Scientific Affairs, LLC
$419
Merck Sharp & Dohme Corporation
$284
Hikma Pharmaceuticals USA
$244
Alexion Pharmaceuticals, Inc.
$242
Mallinckrodt Hospital Products Inc.
$237
Radius Health, Inc.
$230
Antares Pharma, Inc.
$215
Boehringer Ingelheim Pharmaceuticals, Inc.
$210
Organon Llc
$200
SANOFI-AVENTIS U.S. LLC
$171
West-Ward Pharmaceuticals
$128
Flexion Therapeutics, Inc.
$121
Fresenius Kabi USA, LLC
$112
Takeda Pharmaceuticals U.S.A., Inc.
$101
MEDAC PHARMA, INC.
$93
Cumberland Pharmaceuticals, Inc.
$79
MEDEXUS PHARMA, INC.
$63
Kiniksa Pharmaceuticals International, plc
$56
Organon LLC
$48
Progentec Diagnostics, Inc.
$33
Kiniksa Pharmaceuticals, Ltd.
$29
Kyowa Kirin, Inc.
$29
Horizon Pharma plc
$28
ANI Pharmaceuticals, Inc.
$26
Zyla Life Sciences
$26
Mylan Institutional Inc.
$23
SOBI, INC
$22
Actelion Pharmaceuticals US, Inc.
$18
SCILEX PHARMACEUTICALS INC.
$18
Sobi, Inc
$17
Celltrion USA Inc.
$14
Ferring Pharmaceuticals Inc.
$14
Zimmer Biomet Holdings, Inc.
$14
Zyla Life Sciences, Inc.
$14
FIDIA PHARMA USA INC.
$7
Top 3 companies account for 80.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUEXIS · EUFLEXXA · EVENITY · Enbrel · FORTEO · GPS III PLATELET CONCENTRATION SYSTEM · HADLIMA · HUMIRA · Humira · Hymovis · IDACIO · INFLECTRA · KEVZARA · KINERET · KRISTALOSE · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · ORENCIA · OTREXUP · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REDITREX · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · UPTRAVI · Uloric · VIMOVO · XELJANZ · YUFLYMA · ZORVOLEX · ZTLido · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
2,173
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Geslani is a mixed practice specialist, with above-average Medicare volume (top 6% in TX), with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Geslani experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Geslani performed 2,280 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Geslani receive payments from pharmaceutical companies?
Yes. Dr. Geslani received a total of $192,365 from 52 companies across 2,025 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Geslani's costs compare to other internal medicine physicians in Dallas?
Dr. Geslani's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Geslani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Dallas
Browse internal medicine physicians in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology